Company intelligence / Profile preview

Groupe GD COM

Ownership: Private
Development stage: Other

Overview

GD Group is the only manufacturer in Korea that independently produces reagents and consumables specialized in histopathology. Their product line includes innovative solutions such as a formaldehyde-replacement fixative and transporting device reagents for inactivating RNA viruses. The company supplies over 130 organizations including hospitals, laboratories, universities, CROs, and GLPs within Korea and exports internationally. They emphasize ongoing R&D to address global market needs[5].

Modalities: ReagentsConsumablesFixative solutionTransporting device reagents for RNA viruses
Industry: Pathology

Beyond the preview

Go deeper on Groupe GD COM.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Groupe GD COM.

Explore the full profile